MGA identified as immunotherapy target in triple-negative breast cancer
Oct. 8, 2024
Investigators at Nanjing Medical University and The University of Texas MD Anderson Cancer Center recently published data from their research that aimed to identify novel immunotherapy targets in triple-negative breast cancer (TNBC).